Simulating Hyperinflation for 3650 days.

If private bond holdings are going down and the government is running a big deficit then the central bank has to monetize bonds equal to the deficit plus the decrease in private bond holdings.  We don't show the details of the central bank buying bonds here, just the net results.

See blog at http://howfiatdies.blogspot.com for more on hyperinflation, including a hyperinflation FAQ.

Clusters of interacting methods for improving health services network design and delivery. Includes Forrester quotes on statistical vs SD methods and the Modeller's dilemma. Simplified version of IM-14982 combined with IM-17598 and IM-9773

Simple model of the global economy, the global carbon cycle, and planetary energy balance.

The macroeconomic ruel: SPENDING = INCOME = OUTPUT, WHICH DRIVES EMPLOYMENT is presented here in a schematic form. Output can be taken to be equivalent to  GDP. In order to maintain output it is necessary for all the income earned to be spent. If this is not the case, then companies find they have excess unsold stock on their hands and will cut back on production. This, in time, will lead to an increase in unemployment as companies need fewer employees. The shortfall in spending can be made up by any of the three sectors that contribute to total output. However, in cases where  a country has a trade deficit and where the private sector is not spending or investing enough, the only option is for the government to Net Spend i.e. to spend more than it collected in taxes causing a fiscal deficit.

One of the Archetypes that I see is the way out. The Pioneer Seeds bought will directly keep affecting DuPont's Profit until they start buying Ghanaian corn seeds. My Behavior over Time graphs keep disappearing so, I will just explain them instead. DuPont's Profit will keep going up because so many people like buying the pioneer seeds. Soil Erosion will also go up because there will be more plants growing. Farmers profit will go down because more and more farmers are buying the Pioneer seeds. Affordability of Pioneer Seeds is also going down because of there popularity. The amount of GMO labels is also going down because DuPont feels like it will risk there business. The amount of Pioneer Seeds bought is going up because more and more people keep buying them. The amount of Farming Jobs are going up because more and more people think they will get profit in this business and then it starts to stabilize and goes down a little because they realize farming isn't that good. The amount of Pioneer Seeds is affecting how big the harvest is so, the Harvest is going up. The Amount of Ghanaian Seeds bought is going down because there are more and more Pioneer seeds being bought. Dependency on DuPont is increasing because they need there Pioneer Seeds.

This model simulates the economics of buying a home. It was created to compare buying a home against using investment returns to pay for rent. According to Micheal Finke, house prices typically run 20x monthly rental rates. 

A simple model for cc adoption which depends on several condions.

Economic capital growth in a system constrained by a non-renewable resource, Figure 37 from Thinking in Systems by Donella H. Meadows

This is a simplification of the Austerity vs Prosperity model in the hope that it will be easier to understand.

Ocean/atmosphere/biosphere model tuned for interactive economics-based simulations from Y2k on.

This is an economic growth and collapse model based on the Seneca model described by Ugo Bardi. In this implementation, however, direct positive feedback of existing pollution level on pollution increase is replaced with direct positive feedback of existing pollution level on economic loss (i.e. pollution drags down the economy)

Based on the Market and Price simulation model in System Zoo 3. Used in the System Thinking section of Regenerative Economics.

Circular equations WIP for Runy.

This model is based on the article Dynamic modeling of Infectious Diseases, An application to Economic Evaluation of Influenza Vaccination Farmacoeconomics 2008, 26(1): 45-56 .

And EBOLA